Neuralink earns $280M funding round

Neuralink earned a $280 million series D funding round, the company said in an Aug. 7 tweet.

Advertisement

The funding was led by Founders Fund. This comes a few months after Neuralink received FDA approval for human trials of its brain implant.

Neuralink, a company from Elon Musk, seeks to address spinal cord injuries through the brain implant and has been tested in animals. However, some experts are warning the company in light of safety concerns. 

Advertisement

Next Up in Spinal Tech

  • Medtech company Stryker reported sales increases across multiple portfolios in the third quarter, according to financial results posted Oct. 30.…

  • Here are four companies earning FDA clearance for spine technology this month: 1. Elevation Spine’s Saber-C earned FDA clearance for…

Advertisement

Comments are closed.